Skip to content
Recall Observatory FDA recall evidence

Drug product

Pentasa (mesalamine) Controlled-Release Capsules, 250 mg, 240 count bottle, Rx only, Manufactured for Shire US Inc., Lexington, MA --- NDC 54092-189-81

D-0432-2017

December 02, 2016

Class III

Product summary

Firm
Shire PLC
Event
Event 75880
Status
Terminated
Classification
Class III
Quantity
4,520 bottles
Official record key
drug-enforcement:D-0432-2017

Official wording

Reason: Presence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 250 mg capsules

Code information: Lot Number AE7363A, exp 06/30/2019

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Tablets